MILAN, March 4 (Reuters) - Italy's Agnelli family has a 10.1% stake in New York-listed information services provider Clarivate 16A.F through their investment arm Exor EXOR.AS, the two companies said ...

Philips resolved the Respironics litigation, settling for $1.1 billion. And Exor decided to boost its stake in the company. Supportive shareholders' remuneration is linked to Exor's portfolio results, ...

Exor’s FY24 performance was uninspiring, with Stellantis dragging down the very strong contribution from Ferrari. Recent actions—reducing Ferrari concentration, executing a large buyback, and ...

Has already invested almost 4 bln euros in healthcare Has cash firepower of 1.7 bln euros already allocated To receive around 1.1 bln euros in dividends during 2024 Exor NAV rose to 35.5 bln euros ...

22,965,749 Ordinary Shares were validly tendered by Qualifying Shareholders in the Tender Offer and, following application of the scaling-down mechanism set out in the Offer Memorandum, 12,254,495 ...

Monday's announcement is the latest step in the holding company's investment campaign, propelled two years ago by the $9 billion it raised from the sale of its reinsurer PartnerRe to France's Covea.

"Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the company's management and board," the companies said. Italy's Agnelli family has a 10.1% stake in New ...